Drugs Made In America Acquisition II (DMII)
Blank-check company seeking a pharmaceutical-focused business combination.
$10.17
At close+0.02 (+0.15%)
Something off on this page? Send us feedback.
EPSReportedEstimate
———————FY25
Reported———————$0.16
Estimate————————
Surprise————————
RevenueReportedEstimate
———————FY25
Reported———————$0
Estimate————————
Surprise————————
History
| Fiscal year | Estimate | Reported | Surprise |
|---|---|---|---|
| 2025 | — | $0.16 | — |
| Fiscal year | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| 2025 | — | $0.16 | — | — | $0 | — |